Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,713 | Dovepress* | 8,028+ | 1,013 | 9,041 | |
| PubMed Central* | 1,685 | 373 | 2,058 | ||
| Totals | 9,713 | 1,386 | 11,099 | ||
| *Since 19 April 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar